Joanne N. Engel
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Joanne N. Engel has a total of 213 co-authors. Here are the top co-authors by number of shared publications:
Jessica Sherry
University of California San Francisco
8 shared publications- Alexandre Persat
Global Health Institute, School of Life Sciences, École Polytechnique Fédérale de Lausanne (EPFL)
7 shared publications - Cherilyn A. Elwell
Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
7 shared publications Jeffrey R. Johnson
Department of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA 94143, USA
7 shared publicationsCherilyn A. Elwell
University of California San Francisco
6 shared publicationsEleanor McMahon
Department of Medicine, University of California, San Francisco, San Francisco, CA 94143, USA
6 shared publications
Latest Publications
- Open Access
- 14 October 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (10)
The Chlamydia trachomatis effector CT226 directly engages LRRFIP1 to recruit a multiprotein complex that limits inclusion size and progeny production
Chlamydia species secrete a unique class of effector proteins termed inclusion membrane proteins (Incs) that are translocated into the inclusion membrane and reprogram host cell processes to support intracellular growth. Using affinity purification–mass spectrometry, we previously identified an interaction between the early expressed Inc CT226 and a human multiprotein complex comprising leucine-rich repeat Flightless-I-interacting protein 1 (LRRFIP1), LRRFIP2, Flightless-I (FLII), and tropomodulin 3 (TMOD3). Here, we define the molecular basis and functional consequences of this interaction during Chlamydia trachomatis infection. We show that CT226 is both necessary and sufficient to recruit the LRRFIP1/2:FLII:TMOD3 (LFT) complex to the inclusion membrane. In vitro reconstitution with purified proteins demonstrates that the predicted coiled-coil region of CT226 directly binds the N-terminal helix of LRRFIP1. Using in silico structural modeling with AlphaFold-Multimer coupled with mutational validation, we identify key residues that mediate an electrostatic CT226:LRRFIP1 interaction required for LFT recruitment to the inclusion. Unexpectedly, genetic disruption of CT226 or its interaction with the LFT complex results in modest increases in inclusion size and recovery of infectious progeny late in infection, demonstrating that the CT226:LFT interaction modulates C. trachomatis developmental progression. Together, these findings establish the molecular basis of CT226-mediated recruitment of the LFT complex to the inclusion membrane and uncover a previously unrecognized role for this effector–host interaction at late timepoints of the C. trachomatis intracellular developmental cycle. IMPORTANCE: Chlamydia trachomatis is a major cause of sexually transmitted infections and blindness worldwide. This bacterium survives by replicating inside host cells within a membrane-bound compartment, where it deploys specialized proteins to manipulate host processes. These proteins, known as inclusion membrane proteins (Incs), help organize the host–pathogen interface, but the molecular mechanisms by which many Incs engage host factors remain poorly understood. Here, we show that the Inc protein CT226 recruits a host multiprotein complex to the bacterial compartment by directly binding one of its components. Using structural modeling and targeted mutations, we define the molecular interface required for this interaction. Disruption of CT226 or its ability to engage this host complex results in modest increases in inclusion size and production of infectious progeny, suggesting a role for the CT226:host interaction in regulating Chlamydia intracellular development. These findings reveal how a bacterial effector can engage a host protein complex to influence the outcome of infection.
- 14 October 2026
- Published by American Society for Microbiology in mBio
- Vol. 17 (10)
Open AccessThe Chlamydia trachomatis effector CT226 directly engages LRRFIP1 to recruit a multiprotein complex that limits inclusion size and progeny production
Chlamydia species secrete a unique class of effector proteins termed inclusion membrane proteins (Incs) that are translocated into the inclusion membrane and reprogram host cell processes to support intracellular growth. Using affinity purification–mass spectrometry, we previously identified an interaction between the early expressed Inc CT226 and a human multiprotein complex comprising leucine-rich repeat Flightless-I-interacting protein 1 (LRRFIP1), LRRFIP2, Flightless-I (FLII), and tropomodulin 3 (TMOD3). Here, we define the molecular basis and functional consequences of this interaction during Chlamydia trachomatis infection. We show that CT226 is both necessary and sufficient to recruit the LRRFIP1/2:FLII:TMOD3 (LFT) complex to the inclusion membrane. In vitro reconstitution with purified proteins demonstrates that the predicted coiled-coil region of CT226 directly binds the N-terminal helix of LRRFIP1. Using in silico structural modeling with AlphaFold-Multimer coupled with mutational validation, we identify key residues that mediate an electrostatic CT226:LRRFIP1 interaction required for LFT recruitment to the inclusion. Unexpectedly, genetic disruption of CT226 or its interaction with the LFT complex results in modest increases in inclusion size and recovery of infectious progeny late in infection, demonstrating that the CT226:LFT interaction modulates C. trachomatis developmental progression. Together, these findings establish the molecular basis of CT226-mediated recruitment of the LFT complex to the inclusion membrane and uncover a previously unrecognized role for this effector–host interaction at late timepoints of the C. trachomatis intracellular developmental cycle. IMPORTANCE: Chlamydia trachomatis is a major cause of sexually transmitted infections and blindness worldwide. This bacterium survives by replicating inside host cells within a membrane-bound compartment, where it deploys specialized proteins to manipulate host processes. These proteins, known as inclusion membrane proteins (Incs), help organize the host–pathogen interface, but the molecular mechanisms by which many Incs engage host factors remain poorly understood. Here, we show that the Inc protein CT226 recruits a host multiprotein complex to the bacterial compartment by directly binding one of its components. Using structural modeling and targeted mutations, we define the molecular interface required for this interaction. Disruption of CT226 or its ability to engage this host complex results in modest increases in inclusion size and production of infectious progeny, suggesting a role for the CT226:host interaction in regulating Chlamydia intracellular development. These findings reveal how a bacterial effector can engage a host protein complex to influence the outcome of infection.
- Open Access
- 12 August 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (41)
Chemoenzymatic Radiosynthesis of a Gluconate Transporter‐Targeted In Vivo Bacterial Sensor From Clinical [ 18 F]FDG
Many bacteria, but not mammalian cells, can directly import and metabolize extracellular gluconate via gluconate permease (GntP) and kinase (GntK). We hypothesized that fluorine‐18 labeled gluconic acid ([ 18 F]FGA) could leverage unique bacterial gluconate metabolism for pathogen‐specific PET imaging. Here, we report [ 18 F]FGA as a new PET tracer targeting bacterial gluconate metabolism. The chemoenzymatic radiosynthesis of [ 18 F]FGA was simple, only requiring readily available [ 18 F]FDG and glucose oxidase. [ 18 F]FGA showed broad detection sensitivity across multiple bacterial species, including multidrug‐resistant clinical isolates. Staphylococcus aureus transposon mutant studies showed substantial loss of [ 18 F]FGA uptake in GntP and GntK mutants, supporting high specificity for bacterial gluconate metabolism. [ 18 F]FGA PET selectively highlighted live bacterial infection, with high target‐to‐nontarget ratios in S. aureus (36‐fold) and Escherichia coli (30‐fold) in a murine model of myositis. Unlike [ 18 F]FDG, no appreciable uptake of [ 18 F]FGA was detected at sites of sterile inflammation. In a Klebsiella pneumoniae pneumonia model, [ 18 F]FGA showed significantly higher accumulation in the infected lung (5.2 ± 0.8%IA/cc) than in the uninfected lung (0.1 ± 0.0%IA/cc), further supporting its potential for imaging challenging clinical infections. Taken together, [ 18 F]FGA PET may be a useful tool for pathogen‐targeted imaging in clinical practice.
- 12 August 2026
- Published by Wiley in Angewandte Chemie
- Vol. 138 (41)
Open AccessChemoenzymatic Radiosynthesis of a Gluconate Transporter‐Targeted In Vivo Bacterial Sensor From Clinical [ 18 F]FDG
Many bacteria, but not mammalian cells, can directly import and metabolize extracellular gluconate via gluconate permease (GntP) and kinase (GntK). We hypothesized that fluorine‐18 labeled gluconic acid ([ 18 F]FGA) could leverage unique bacterial gluconate metabolism for pathogen‐specific PET imaging. Here, we report [ 18 F]FGA as a new PET tracer targeting bacterial gluconate metabolism. The chemoenzymatic radiosynthesis of [ 18 F]FGA was simple, only requiring readily available [ 18 F]FDG and glucose oxidase. [ 18 F]FGA showed broad detection sensitivity across multiple bacterial species, including multidrug‐resistant clinical isolates. Staphylococcus aureus transposon mutant studies showed substantial loss of [ 18 F]FGA uptake in GntP and GntK mutants, supporting high specificity for bacterial gluconate metabolism. [ 18 F]FGA PET selectively highlighted live bacterial infection, with high target‐to‐nontarget ratios in S. aureus (36‐fold) and Escherichia coli (30‐fold) in a murine model of myositis. Unlike [ 18 F]FDG, no appreciable uptake of [ 18 F]FGA was detected at sites of sterile inflammation. In a Klebsiella pneumoniae pneumonia model, [ 18 F]FGA showed significantly higher accumulation in the infected lung (5.2 ± 0.8%IA/cc) than in the uninfected lung (0.1 ± 0.0%IA/cc), further supporting its potential for imaging challenging clinical infections. Taken together, [ 18 F]FGA PET may be a useful tool for pathogen‐targeted imaging in clinical practice.
- Open Access
- 11 August 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (41)
Chemoenzymatic Radiosynthesis of a Gluconate Transporter‐Targeted In Vivo Bacterial Sensor From Clinical [ 18 F]FDG
Many bacteria, but not mammalian cells, can directly import and metabolize extracellular gluconate via gluconate permease (GntP) and kinase (GntK). We hypothesized that fluorine‐18 labeled gluconic acid ([ 18 F]FGA) could leverage unique bacterial gluconate metabolism for pathogen‐specific PET imaging. Here, we report [ 18 F]FGA as a new PET tracer targeting bacterial gluconate metabolism. The chemoenzymatic radiosynthesis of [ 18 F]FGA was simple, only requiring readily available [ 18 F]FDG and glucose oxidase. [ 18 F]FGA showed broad detection sensitivity across multiple bacterial species, including multidrug‐resistant clinical isolates. Staphylococcus aureus transposon mutant studies showed substantial loss of [ 18 F]FGA uptake in GntP and GntK mutants, supporting high specificity for bacterial gluconate metabolism. [ 18 F]FGA PET selectively highlighted live bacterial infection, with high target‐to‐nontarget ratios in S. aureus (36‐fold) and Escherichia coli (30‐fold) in a murine model of myositis. Unlike [ 18 F]FDG, no appreciable uptake of [ 18 F]FGA was detected at sites of sterile inflammation. In a Klebsiella pneumoniae pneumonia model, [ 18 F]FGA showed significantly higher accumulation in the infected lung (5.2 ± 0.8%IA/cc) than in the uninfected lung (0.1 ± 0.0%IA/cc), further supporting its potential for imaging challenging clinical infections. Taken together, [ 18 F]FGA PET may be a useful tool for pathogen‐targeted imaging in clinical practice.
- 11 August 2026
- Published by Wiley in Angewandte Chemie International Edition
- Vol. 65 (41)
Open AccessChemoenzymatic Radiosynthesis of a Gluconate Transporter‐Targeted In Vivo Bacterial Sensor From Clinical [ 18 F]FDG
Many bacteria, but not mammalian cells, can directly import and metabolize extracellular gluconate via gluconate permease (GntP) and kinase (GntK). We hypothesized that fluorine‐18 labeled gluconic acid ([ 18 F]FGA) could leverage unique bacterial gluconate metabolism for pathogen‐specific PET imaging. Here, we report [ 18 F]FGA as a new PET tracer targeting bacterial gluconate metabolism. The chemoenzymatic radiosynthesis of [ 18 F]FGA was simple, only requiring readily available [ 18 F]FDG and glucose oxidase. [ 18 F]FGA showed broad detection sensitivity across multiple bacterial species, including multidrug‐resistant clinical isolates. Staphylococcus aureus transposon mutant studies showed substantial loss of [ 18 F]FGA uptake in GntP and GntK mutants, supporting high specificity for bacterial gluconate metabolism. [ 18 F]FGA PET selectively highlighted live bacterial infection, with high target‐to‐nontarget ratios in S. aureus (36‐fold) and Escherichia coli (30‐fold) in a murine model of myositis. Unlike [ 18 F]FDG, no appreciable uptake of [ 18 F]FGA was detected at sites of sterile inflammation. In a Klebsiella pneumoniae pneumonia model, [ 18 F]FGA showed significantly higher accumulation in the infected lung (5.2 ± 0.8%IA/cc) than in the uninfected lung (0.1 ± 0.0%IA/cc), further supporting its potential for imaging challenging clinical infections. Taken together, [ 18 F]FGA PET may be a useful tool for pathogen‐targeted imaging in clinical practice.
- Open Access
- 8 April 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (4) , 115536
Antagonistic response regulators spatially regulate receptor methylation in the Pseudomonas aeruginosa Pil-Chp surface sensing system
- 8 April 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (4) , 115536
Open AccessAntagonistic response regulators spatially regulate receptor methylation in the Pseudomonas aeruginosa Pil-Chp surface sensing system
- Open Access
- 6 April 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (4) , 115509
The Chlamydia effector Dre1 binds dynactin to reposition host organelles during infection
- 6 April 2025
- Published by Elsevier in Cell Reports
- Vol. 44 (4) , 115509
Open AccessThe Chlamydia effector Dre1 binds dynactin to reposition host organelles during infection
- Open Access
- 14 January 2025
- Published by Oxford University Press (OUP) in FEMS Microbiology Reviews
- Vol. 49
Forging new paths in bacterial motility and sensory transduction: highlights from BLAST XVIII
The Bacterial Locomotion And Signal Transduction (BLAST) conference was founded in 1991 and has been held biennially thereafter. While BLAST meetings have typically covered two-component and chemotactic signaling, as well as aspects of motor and flagellum, this year’s program broadened its scope and included emerging areas of research, such as microbial signal perception, cellular signal processing, downstream physiological impacts of bacterial signaling, microbe interactions and communities, integrative approaches, and technology innovations. This review summarizes the oral presentations from BLAST XVIII, held in January 2025 in Cancun, Mexico.
- 14 January 2025
- Published by Oxford University Press (OUP) in FEMS Microbiology Reviews
- Vol. 49
Open AccessForging new paths in bacterial motility and sensory transduction: highlights from BLAST XVIII
The Bacterial Locomotion And Signal Transduction (BLAST) conference was founded in 1991 and has been held biennially thereafter. While BLAST meetings have typically covered two-component and chemotactic signaling, as well as aspects of motor and flagellum, this year’s program broadened its scope and included emerging areas of research, such as microbial signal perception, cellular signal processing, downstream physiological impacts of bacterial signaling, microbe interactions and communities, integrative approaches, and technology innovations. This review summarizes the oral presentations from BLAST XVIII, held in January 2025 in Cancun, Mexico.
- Open Access
- 17 August 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (8) , 114624
The Chlamydia effector IncE employs two short linear motifs to reprogram host vesicle trafficking
- 17 August 2024
- Published by Elsevier in Cell Reports
- Vol. 43 (8) , 114624
Open AccessThe Chlamydia effector IncE employs two short linear motifs to reprogram host vesicle trafficking
- Open Access
- 2 July 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (7) , e0045324
The Chlamydia trachomatis Inc Tri1 interacts with TRAF7 to displace native TRAF7 interacting partners
Chlamydia trachomatis is the leading cause of bacterial sexually transmitted infections in the USA and of preventable blindness worldwide. This obligate intracellular pathogen replicates within a membrane-bound inclusion, but how it acquires nutrients from the host while avoiding detection by the innate immune system is incompletely understood. C. trachomatis accomplishes this in part through the translocation of a unique set of effectors into the inclusion membrane, the inc lusion membrane proteins (Incs). Incs are ideally positioned at the host-pathogen interface to reprogram host signaling by redirecting proteins or organelles to the inclusion. Using a combination of co-affinity purification, immunofluorescence confocal imaging, and proteomics, we characterize the interaction between an early-expressed Inc of unknown function, Tri1, and tumor necrosis factor receptor-associated factor 7 (TRAF7). TRAF7 is a multi-domain protein with a RING finger ubiquitin ligase domain and a C-terminal WD40 domain. TRAF7 regulates several innate immune signaling pathways associated with C. trachomatis infection and is mutated in a subset of tumors. We demonstrate that Tri1 and TRAF7 specifically interact during infection and that TRAF7 is recruited to the inclusion. We further show that the predicted coiled-coil domain of Tri1 is necessary to interact with the TRAF7 WD40 domain. Finally, we demonstrate that Tri1 displaces the native TRAF7 binding partners, mitogen-activated protein kinase kinase kinase 2 (MEKK2), and MEKK3. Together, our results suggest that by displacing TRAF7 native binding partners, Tri1 has the capacity to alter TRAF7 signaling during C. trachomatis infection. IMPORTANCE: Chlamydia trachomatis is the leading cause of bacterial sexually transmitted infections in the USA and preventable blindness worldwide. Although easily treated with antibiotics, the vast majority of infections are asymptomatic and therefore go untreated, leading to infertility and blindness. This obligate intracellular pathogen evades the immune response, which contributes to these outcomes. Here, we characterize the interaction between a C. trachomatis -secreted effector, Tri1, and a host protein involved in innate immune signaling, TRAF7. We identified host proteins that bind to TRAF7 and demonstrated that Tri1 can displace these proteins upon binding to TRAF7. Remarkably, the region of TRAF7 to which these host proteins bind is often mutated in a subset of human tumors. Our work suggests a mechanism by which Tri1 may alter TRAF7 signaling and has implications not only in the pathogenesis of C. trachomatis infections but also in understanding the role of TRAF7 in cancer.
- 2 July 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (7) , e0045324
Open AccessThe Chlamydia trachomatis Inc Tri1 interacts with TRAF7 to displace native TRAF7 interacting partners
Chlamydia trachomatis is the leading cause of bacterial sexually transmitted infections in the USA and of preventable blindness worldwide. This obligate intracellular pathogen replicates within a membrane-bound inclusion, but how it acquires nutrients from the host while avoiding detection by the innate immune system is incompletely understood. C. trachomatis accomplishes this in part through the translocation of a unique set of effectors into the inclusion membrane, the inc lusion membrane proteins (Incs). Incs are ideally positioned at the host-pathogen interface to reprogram host signaling by redirecting proteins or organelles to the inclusion. Using a combination of co-affinity purification, immunofluorescence confocal imaging, and proteomics, we characterize the interaction between an early-expressed Inc of unknown function, Tri1, and tumor necrosis factor receptor-associated factor 7 (TRAF7). TRAF7 is a multi-domain protein with a RING finger ubiquitin ligase domain and a C-terminal WD40 domain. TRAF7 regulates several innate immune signaling pathways associated with C. trachomatis infection and is mutated in a subset of tumors. We demonstrate that Tri1 and TRAF7 specifically interact during infection and that TRAF7 is recruited to the inclusion. We further show that the predicted coiled-coil domain of Tri1 is necessary to interact with the TRAF7 WD40 domain. Finally, we demonstrate that Tri1 displaces the native TRAF7 binding partners, mitogen-activated protein kinase kinase kinase 2 (MEKK2), and MEKK3. Together, our results suggest that by displacing TRAF7 native binding partners, Tri1 has the capacity to alter TRAF7 signaling during C. trachomatis infection. IMPORTANCE: Chlamydia trachomatis is the leading cause of bacterial sexually transmitted infections in the USA and preventable blindness worldwide. Although easily treated with antibiotics, the vast majority of infections are asymptomatic and therefore go untreated, leading to infertility and blindness. This obligate intracellular pathogen evades the immune response, which contributes to these outcomes. Here, we characterize the interaction between a C. trachomatis -secreted effector, Tri1, and a host protein involved in innate immune signaling, TRAF7. We identified host proteins that bind to TRAF7 and demonstrated that Tri1 can displace these proteins upon binding to TRAF7. Remarkably, the region of TRAF7 to which these host proteins bind is often mutated in a subset of human tumors. Our work suggests a mechanism by which Tri1 may alter TRAF7 signaling and has implications not only in the pathogenesis of C. trachomatis infections but also in understanding the role of TRAF7 in cancer.
- Open Access
The Chlamydia trachomatis secreted effector CebN targets nucleoporins and Rae1 to antagonize STAT1 nuclear import
To usurp host defenses and establish a replicative niche, obligate intracellular pathogens are tasked with remodeling the host cell using a comparatively small repertoire of effector proteins. For Chlamydia trachomatis ( C.t ), discovery of secreted proteins and their host targets has been particularly challenging due to the bacterium’s historical genetic intractability. Using affinity purification-mass spectrometry, we defined host interaction partners for 21 secreted effector proteins, providing the first comprehensive type III secretion system (T3SS) effector- host interactome generated during infection. Among these, we show that the C-terminus of CebN (CT584) binds multiple nucleoporins and Rae1, host factors previously associated only with viral immune evasion. Remarkably, we shown that CebN localizes to the nuclear envelope not only in infected cells but also in uninfected bystander cells. Functionally, CebN is both necessary and sufficient to perturb STAT1 nuclear import following IFN-γ stimulation and its expression is critical for C.t. survival, as evidenced by reduced bacterial replication and smaller inclusions in cells infected with a CebN mutant. Together, these finds expand our understanding of chlamydia effector biology and highlight novel bacterial strategies for manipulating host defenses at the nuclear pore. SIGNIFICANCE: Chlamydia trachomatis ( C.t. ) is a leading cause of sexually transmitted infections and blindness, yet the molecular mechanisms it uses to manipulate host defenses remain poorly defined. Unlike many pathogens, C.t. relies on a limited set of effectors to remodel the host cell and establish its niche. We identified host targets for 21 C.t. effector proteins. Focusing on CebN, we show that it binds nucleoporins and Rae1, host factors previously linked only to viral immune antagonism. CebN localizes to the nuclear envelope of both infected and bystander cells, and is critical for replication, inclusion development, and perturbation of STAT1 nuclear import following IFN-γ stimulation. These findings uncover a novel strategy by which C.t. manipulates nuclear pore function to evade host defenses and establish infection.
Open AccessThe Chlamydia trachomatis secreted effector CebN targets nucleoporins and Rae1 to antagonize STAT1 nuclear import
To usurp host defenses and establish a replicative niche, obligate intracellular pathogens are tasked with remodeling the host cell using a comparatively small repertoire of effector proteins. For Chlamydia trachomatis ( C.t ), discovery of secreted proteins and their host targets has been particularly challenging due to the bacterium’s historical genetic intractability. Using affinity purification-mass spectrometry, we defined host interaction partners for 21 secreted effector proteins, providing the first comprehensive type III secretion system (T3SS) effector- host interactome generated during infection. Among these, we show that the C-terminus of CebN (CT584) binds multiple nucleoporins and Rae1, host factors previously associated only with viral immune evasion. Remarkably, we shown that CebN localizes to the nuclear envelope not only in infected cells but also in uninfected bystander cells. Functionally, CebN is both necessary and sufficient to perturb STAT1 nuclear import following IFN-γ stimulation and its expression is critical for C.t. survival, as evidenced by reduced bacterial replication and smaller inclusions in cells infected with a CebN mutant. Together, these finds expand our understanding of chlamydia effector biology and highlight novel bacterial strategies for manipulating host defenses at the nuclear pore. SIGNIFICANCE: Chlamydia trachomatis ( C.t. ) is a leading cause of sexually transmitted infections and blindness, yet the molecular mechanisms it uses to manipulate host defenses remain poorly defined. Unlike many pathogens, C.t. relies on a limited set of effectors to remodel the host cell and establish its niche. We identified host targets for 21 C.t. effector proteins. Focusing on CebN, we show that it binds nucleoporins and Rae1, host factors previously linked only to viral immune antagonism. CebN localizes to the nuclear envelope of both infected and bystander cells, and is critical for replication, inclusion development, and perturbation of STAT1 nuclear import following IFN-γ stimulation. These findings uncover a novel strategy by which C.t. manipulates nuclear pore function to evade host defenses and establish infection.
- Open Access
The Chlamydia effector IncE employs two short linear motifs to reprogram host vesicle trafficking
Summary: Chlamydia trachomatis, a leading cause of bacteria sexually transmitted infections, creates a specialized intracellular replicative niche by translocation and insertion of a diverse array of effectors (Incs) into the inclusion membrane. Here, we characterize IncE, a multi-functional Inc that encodes two non-overlapping short linear motifs (SLiMs) within its short cytosolic C-terminus. The proximal SLiM mimics an R-SNARE motif to recruit syntaxin (STX) 7 and 12-containing vesicles to the inclusion. The distal SLiM mimics the Sorting Nexin (SNX) 5 and 6 cargo binding site to recruit SNX6-containing vesicles to the inclusion. By simultaneously binding to two distinct vesicle classes, IncE reprograms host cell trafficking to promote the formation of a class of hybrid vesicles at the inclusion that are required for C. trachomatis intracellular development. Our work suggests that Incs may have evolved SLiMs to facilitate rapid evolution in a limited protein space to disrupt host cell processes.
Open AccessThe Chlamydia effector IncE employs two short linear motifs to reprogram host vesicle trafficking
Summary: Chlamydia trachomatis, a leading cause of bacteria sexually transmitted infections, creates a specialized intracellular replicative niche by translocation and insertion of a diverse array of effectors (Incs) into the inclusion membrane. Here, we characterize IncE, a multi-functional Inc that encodes two non-overlapping short linear motifs (SLiMs) within its short cytosolic C-terminus. The proximal SLiM mimics an R-SNARE motif to recruit syntaxin (STX) 7 and 12-containing vesicles to the inclusion. The distal SLiM mimics the Sorting Nexin (SNX) 5 and 6 cargo binding site to recruit SNX6-containing vesicles to the inclusion. By simultaneously binding to two distinct vesicle classes, IncE reprograms host cell trafficking to promote the formation of a class of hybrid vesicles at the inclusion that are required for C. trachomatis intracellular development. Our work suggests that Incs may have evolved SLiMs to facilitate rapid evolution in a limited protein space to disrupt host cell processes.